Pregled bibliografske jedinice broj: 438931
Genetic and protein changes of E-cadherin in meningiomas
Genetic and protein changes of E-cadherin in meningiomas // Journal of cancer research and clinical oncology, 136 (2010), 5; 695-702 doi:10.1007/s00432-009-0708-z (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 438931 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Genetic and protein changes of E-cadherin in meningiomas
Autori
Pećina-Šlaus, Nives ; Nikuševa Martić, Tamara ; Deak, Adam Jakov ; Zeljko, Martina ; Hrašćan, Reno ; Tomas, Davor ; Musani, Vesna
Izvornik
Journal of cancer research and clinical oncology (0171-5216) 136
(2010), 5;
695-702
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
E-cadherin ; CDH1 ; loss of heterozygosity ; immunostaining ; meningiomas ; tumors of the CNS ; wnt signaling pathway
Sažetak
PURPOSE: The molecular mechanisms and candidate genes involved in development of meningiomas still needs investigation and elucidation. METHODS: In the present study 60 meningiomas were analyzed regarding changes of tumor suppressor gene E-cadherin (CDH1), a component of adherens junction and an indirect modulator of the wnt signaling. Gene instability was tested by polymerase chain reaction/loss of heterozygosity (LOH) method. Protein expression was analyzed by immunohistochemistry. RESULTS: The results of our analysis showed altogether 32% of samples with LOH of the CDH1 gene. Interestingly, another type of genomic instability was detected ; replication error-positive samples (RER+). Three out of 28 heterozygous samples were RER+ (11%). The instability is the result of impaired cellular mismatch repair. Fibrous and angiomatous cases showed higher percent of genetic changes, 67 and 75%, respectively. Immunostaining showed that overall 73% of samples had downregulation of E-cadherin expression. Intense downregulation of E-cadherin was noticed in tumors with grades II and III. Five out of nine samples with LOH were accompanied with the downregulation of E-cadherin protein expression (56%). One RER+ sample had lower expression of E-cadherin. We noticed that 36.4% of samples with lower E-cadherin expression had beta-catenin located in the nucleus. Also, 75% of samples with genomic instabilities had beta-catenin in the nucleus. Our findings demonstrated that there is significant association between the genetic changes of CDH1 and the nuclear localization of beta-catenin protein (chi(2) = 5.25, df = 1, P < 0.022). Beta-catenin was progressively upregulated from meningothelial to atypical, while 60% of anaplastic showed upregulation and nuclear localization of the protein. CONCLUSIONS: Our results suggest that genetic instabilities of the E-cadherin gene have a role in meningioma development and progression. Detected microsatellite instability indicates that mismatch repair may also be targeted in meningioma.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
058-0582261-2246 - Utjecaj mutagena i antimutagena na molekularne procese u stanici (Hrašćan, Reno, MZOS ) ( CroRIS)
108-1081870-1884 - Razvojna neuropatologija genetskih malformacija moždane kore čovjeka (Krušlin, Božo, MZOS ) ( CroRIS)
108-1081870-1905 - Uloga signalnog puta wnt u tumorigenezi i embriogenezi mozga (Pećina-Šlaus, Nives, MZOS ) ( CroRIS)
Ustanove:
KBC "Sestre Milosrdnice"
Profili:
Tamara Nikuševa Martić
(autor)
Vesna Musani
(autor)
Davor Tomas
(autor)
Reno Hrašćan
(autor)
Nives Pećina-Šlaus
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE